Drugs for Life , livre ebook

277

pages

English

Ebooks

2012

Écrit par
Dumit Joseph Dumit

Publié par
Duke University Press

Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Découvre YouScribe et accède à tout notre catalogue !

Je m'inscris

Découvre YouScribe et accède à tout notre catalogue !

Je m'inscris

277

pages

English

Ebooks

2012

Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Publié par

Duke University Press

Date de parution

03 septembre 2012

Nombre de lectures

EAN13

9780822393481

Langue

English

Poids de l'ouvrage

1 Mo

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.

Voir

Publié par

Duke University Press

Date de parution

03 septembre 2012

EAN13

9780822393481

Langue

English

Poids de l'ouvrage

1 Mo

FOR DRUGS LIFE

EXPERIMENTAL FUTURES TechnologIcal LIves, ScIentIic Arts, AnthropologIcal VoIces

A S E R I E S E  I T E  b y Michael M. J. Fischer and Joseph Dumit

DRUGS FOR LIFE

How Pharmaceutical Companies Deîne Our Health

Joseph Dumit

| | Duke UniversitY PressDurham and London2012

Āll rights reserved

Printed in the United Śtates of Āmerica on acid-free paper ♾

Ypeset in Ścala BY seng ïnformation ŚYstems, ïnc.

LiBrarY of Congress Cataloging-in-PuBlication Data appear on the last printed page of this Book.

for SylvIa

CONTENTS

105

135

181

197

List of ïllustrations

Ācknowledgments

INTRODUCTION

ONEesponding to Facts

TWOPharmaceutical Witnessing and Direct-to-Consumer Ādvertising

THREEHaving to Grow Medicine

FOURMass Health: ïllness ïs a Line ou Cross

FIVEMoving the Lines: Deciding on hresholds

SIXKnowing our NumBers: Pharmaceutical LifestYles

CONCLUSIONLiving in a World of Śurplus Health: FrequentlY Āsked Questions

219 Notes

239 eferences

257

ïndex

ILLUSTRATIONS

FIGURE 1“Āre ou the Picture of Health?” 2 FIGURE 2op therapeutic classes of drugs BY U.Ś. dispensed prescriptions, 2010 3 FIGURE 3Personal healthcare expenditures, BY tYpe of expenditure, 1965–2018 9 FIGURE 411“‘Get well soon’? We prefer, ‘ŚtaY healthier longer’” FIGURE 5“How did all these treatments compare in the longer run?” 37 FIGURE 6“ProBlems Tç [Direct-to-Consumer] Ādvertising Creates for MY Patients and Practice” 57

FIGURE 759Depression awareness commercial FIGURE 8Cholesterol awareness commercial 61 FIGURE 970Fosamax Bone-densitY test commercial FIGURE 1074Zoloft commercial FIGURE 11Zoloft commercial exemplifYing liminalitY 75 FIGURE 1279ipolar awareness commercial FIGURE 13Éexor XR weBsite 81 FIGURE 1495“Converting Patients to Volume” FIGURE 1599“Product Development: he ‘Classical’ Design” FIGURE 16“Commercial ïnputs” 100

Voir